NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 14, 2025 $2.25 +8.70% $2.32 V 96.98% 1
Jul 14, 2025 Bullish $2.32 V 1
Jul 11, 2025 $1.99 -1.59% $2.07 X 96.03% 0
Jul 11, 2025 $1.97 +1.03% $2.07 V 95.17% 1
Jul 9, 2025 $1.86 -1.76% $1.95 X 95.22% 0
Jul 9, 2025 $2.00 +7.53% $1.95 V 97.44% 1
Jul 7, 2025 $1.71 -4.05% $1.86 X 91.83% 0
Jul 7, 2025 $1.73 -2.95% $1.86 X 92.88% 0
Jul 7, 2025 $2.00 +12.36% $1.86 V 92.47% 1
Jul 2, 2025 $1.70 +7.59% $1.71 V 99.42% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE